ALR Technologies Receives FCC License for Their Patient Health Management Compliance System, the Constant Health Companion
WINSTON-SALEM, NC -- (MARKET WIRE) -- January 11, 2007 -- ALR Technologies, Inc. (OTCBB: ALRT)
announces that they have received their FCC license for the data communications
modem for their patient health
management compliance system, one of the crucial final steps prior to
full commercial availability. The communications modem allows for remote
monitoring of a patient's
compliance with disease management treatments, medications and other
activities. The communications modem also allows for remote reprogramming
of the reminder times and other essential information as well as messaging
to the patient about upcoming appointments, precautionary reminders and
more.
According to Stan Cruitt, President of ALR Technologies, the benefits
provided by the Constant Health Companion™ can improve health outcomes
as well as reduce cost of care. "Our compliance system has proven to
generate improved health outcome and the long term contributions to
healthier and a better quality of life as well as a significant reduction
in the cost of healthcare, all of which are serious milestones in health
management in the US. Current disease management practice in
the US has a significant gap in care that our compliance system fills."
The Constant Health Companion is a compliance reminder and monitoring
system that alerts the patient when it's time to take a medication or
treatment and displays the exact actions to take on a screen; the patient's
compliance can be remotely monitored by a health care provider or family
member. The Constant Health Companion has been used in numerous pilots
with positive results since February of 2006. Missed medications and
treatments or even lateness of administration can result in adverse affects
and complications often leading to unnecessary and preventable
hospitalization and additional health care expense.
About ALR Technologies Inc:
ALR Technologies, Inc. (ALRT)
specializes in health and disease management products and services, and
designs and manufactures health management compliance products and compliance monitoring and
intervention systems to meet the needs for several targeted user groups.
ALRT's system, branded Constant Health
Companion, fills a serious gap in standard disease management practices
in the US. It provides for continued compliance oversight to help keep
people healthy, whether they suffer from diabetes, heart disease, asthma,
have had an organ transplant or other serious conditions. More information
on ALR Technologies and its products can be found at http://www.alrt.com.
More information about the Constant Health Companion can be found at:
http://www.alrt.com/products/alrt500.html.
This release contains certain "forward-looking statements" relating to ALR
Technologies' business, and these statements reflect the current views of
ALR Technologies with respect to future events and are subject to certain
risks, uncertainties and assumptions. When used, the words "estimate,"
"expect," "anticipate," "believe" and similar expressions are intended to
identify such forward-looking statements. There are many factors that
could cause the actual results, performance or achievements of ALR
Technologies and its products to be materially different from any future
results, performances or achievements that may be expressed or implied by
such forward-looking statements. Further management discussions of risks
and uncertainties can be found in the company's quarterly filings with the
Securities Exchange Commission.
Contact Information: Public and Investor Relations:
Mercom Capital Group, llc
tel: 1.512.828.6645
e-mail: Email Contact